Literature DB >> 29636890

Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-β1/Smads signaling pathway.

Zongtao Hu1,2, Feng Qin3, Shile Gao1,4, Yilan Zhen4, Dake Huang5, Liuyi Dong4.   

Abstract

AIM: This study aimed to investigate the protective effects of paeoniflorin (PAE) on radiation-induced hepatic fibrosis in a rat model.
METHODS: Fifty healthy male Sprague-Dawley rats were randomly assigned to normal control group, hepatic fibrosis group, and PAE treatment groups. X-ray exposure was employed to establish radiation-induced hepatic fibrosis model. PAE was administered once daily, and rats were sacrificed at week 26 after irradiation. The liver histopathology was evaluated under a light microscope after HE staining and Masson staining. Meanwhile, the protein expression of transforming growth factor-beta 1 (TGF-β1), Smad3/4 and Smad7 was detected by immunohistochemistry.
RESULTS: Radiation-induced liver damage and collagen deposition were observed in the model group as compared to normal control group, but PAE treatment significantly attenuated the liver injury and reduce collagen deposition (P<0.05 or 0.01). The hepatic hydroxyproline content and serum levels of TGF-β1, hyaluronic acid, ro-collagen type III and laminin markedly increased in model group as compared to control group (P<0.01), but they decreased dramatically after PAE treatment. The expression of TGF-β1, Smad3/4 and Smad7 in the liver increased significantly in model group as compared to control group (P<0.01), and PAE could down-regulate the expression of Smad3/4 and up-regulate Smad7 expression (P<0.05 or 0.01). The activities of serum amino-transferase and aspartate aminotransferase were significantly higher in hepatic fibrosis group than in normal control group, but PAE treatment markedly reduced them (P<0.05).
CONCLUSION: PAE can inhibit the radiation induced hepatic fibrosis via regulating TGF-β1/Smads signaling pathway.

Entities:  

Keywords:  Paeoniflorin; Smads; radiation-induced hepatic fibrosis; transforming growth factor-beta 1

Year:  2018        PMID: 29636890      PMCID: PMC5883141     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  29 in total

1.  Effects of insulin-like growth factor binding protein-related protein 1 in mice with hepatic fibrosis induced by thioacetamide.

Authors:  Li-xin Liu; Hai-yan Zhang; Qian-qian Zhang; Xiao-hong Guo
Journal:  Chin Med J (Engl)       Date:  2010-09       Impact factor: 2.628

2.  Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.

Authors:  Hiroyuki Kaneda; Etsuko Hashimoto; Satoru Yatsuji; Katsutoshi Tokushige; Keiko Shiratori
Journal:  J Gastroenterol Hepatol       Date:  2006-09       Impact factor: 4.029

3.  Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts.

Authors:  Jürgen Kopp; Ellen Preis; Harun Said; Bernd Hafemann; Lucia Wickert; Axel M Gressner; Norbert Pallua; Steven Dooley
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

Review 4.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

5.  Paeoniflorin suppresses inflammatory mediator production and regulates G protein-coupled signaling in fibroblast-like synoviocytes of collagen induced arthritic rats.

Authors:  L L Zhang; W Wei; N P Wang; Q T Wang; J Y Chen; Y Chen; H Wu; X Y Hu
Journal:  Inflamm Res       Date:  2008-08       Impact factor: 4.575

Review 6.  TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.

Authors:  Fengyun Xu; Changwei Liu; Dandan Zhou; Lei Zhang
Journal:  J Histochem Cytochem       Date:  2016-01-08       Impact factor: 2.479

7.  Inhibitory effect of paeoniflorin on the inflammatory vicious cycle between adipocytes and macrophages.

Authors:  Boren Jiang; Jie Qiao; Yuguo Yang; Yingli Lu
Journal:  J Cell Biochem       Date:  2009-04-24       Impact factor: 4.429

8.  Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.

Authors:  Giovanni Latella; Antonella Vetuschi; Roberta Sferra; Valentina Catitti; Angela D'Angelo; Giuliana Zanninelli; Kathleen C Flanders; Eugenio Gaudio
Journal:  Liver Int       Date:  2009-04-28       Impact factor: 5.828

9.  Evaluation of hepatoprotective effect of Amalkadi Ghrita against carbon tetrachloride-induced hepatic damage in rats.

Authors:  Girish S Achliya; Sudhir G Wadodkar; Avinash K Dorle
Journal:  J Ethnopharmacol       Date:  2004-02       Impact factor: 4.360

Review 10.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

View more
  12 in total

1.  Total glucosides of paeony inhibits liver fibrosis and inflammatory response associated with cirrhosis via the FLI1/NLRP3 axis.

Authors:  Jie Zhang; Yiwei Fu; Bin Yang; Xiaoxing Xiang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Sedum sarmentosum Total Flavonoids Alleviate Schistosomiasis-Induced Liver Fibrosis by Altering TGF-β1 and Smad7 Expression.

Authors:  Peng-Chun Yang; Wei-Zhe Bai; Jing Wang; Cai-Hua Yan; Wei-Feng Huang; Shi-Zhu Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-26       Impact factor: 2.629

3.  Fugan Wan alleviates hepatic fibrosis by inhibiting ACE/Ang II/AT-1R signaling pathway and enhancing ACE2/Ang 1-7/Mas signaling pathway in hepatic fibrosis rat models.

Authors:  Shu Li; Wei Zhao; Yanyan Tao; Chenghai Liu
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

4.  Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.

Authors:  Min Yu; Liyao Peng; Ping Liu; Mingxia Yang; Hong Zhou; Yirui Ding; Jingjing Wang; Wen Huang; Qi Tan; Yanli Wang; Weiping Xie; Hui Kong; Hong Wang
Journal:  Drug Des Devel Ther       Date:  2020-03-19       Impact factor: 4.162

5.  Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway in vivo.

Authors:  Jie Zhou; Yong Tan; Xudong Wang; Meihong Zhu
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

6.  Kinsenoside Protects Against Radiation-Induced Liver Fibrosis via Downregulating Connective Tissue Growth Factor Through TGF-β1 Signaling.

Authors:  Xiaoqi Nie; Qianqian Yu; Long Li; Minxiao Yi; Bili Wu; Yongbiao Huang; Yonghui Zhang; Hu Han; Xianglin Yuan
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

7.  CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop.

Authors:  Hao Niu; Li Zhang; Biao Wang; Guang-Cong Zhang; Juan Liu; Zhi-Feng Wu; Shi-Suo Du; Zhao-Chong Zeng
Journal:  J Clin Transl Hepatol       Date:  2022-02-28

Review 8.  Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases-A Mini Review.

Authors:  Xiao Ma; Wenwen Zhang; Yinxiao Jiang; Jianxia Wen; Shizhang Wei; Yanling Zhao
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

9.  Harnessing X-Ray Energy-Dependent Attenuation of Bismuth-Based Nanoprobes for Accurate Diagnosis of Liver Fibrosis.

Authors:  Shiman Wu; Xianfu Meng; Xingwu Jiang; Yelin Wu; Shaojie Zhai; Xiaoshuang Wang; Yanyan Liu; Jiawen Zhang; Xinxin Zhao; Yan Zhou; Wenbo Bu; Zhenwei Yao
Journal:  Adv Sci (Weinh)       Date:  2021-03-16       Impact factor: 16.806

10.  A pharmacokinetics-pharmacodynamics study of single-dose total glucosides of paeony capsule on reducing serum total bile acid in hepatic injury rats.

Authors:  Ninghua Jiang; Bohong Zheng; Yihan Feng; Lei Yin; Yuanrong Liu; Lujing Cao; Ning Zheng; Suxiang Wu; Baoyue Ding; Xuan Huang; Jeffrey Wang; Shuyu Zhan
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.